Cargando…
Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH
Non-alcoholic steatohepatitis (NASH) is a clinically serious stage of non-alcoholic fatty liver disease (NAFLD). Histologically characterized by hepatocyte ballooning, immune cell infiltration, and fibrosis, NASH, at a molecular level, involves lipid-induced hepatocyte death and cytokine production....
Autores principales: | Tewari, Archana, Rajak, Sangam, Raza, Sana, Gupta, Pratima, Chakravarti, Bandana, Srivastava, Jyotika, Chaturvedi, Chandra P., Sinha, Rohit A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614796/ https://www.ncbi.nlm.nih.gov/pubmed/37484201 http://dx.doi.org/10.3390/cells12141845 |
Ejemplares similares
-
ULK1 Signaling in the Liver: Autophagy Dependent and Independent Actions
por: Rajak, Sangam, et al.
Publicado: (2022) -
MTORC1 inhibition drives crinophagic degradation of glucagon
por: Rajak, Sangam, et al.
Publicado: (2021) -
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Raza, Sana, et al.
Publicado: (2019) -
Targeting bile acids and lipotoxicity for NASH treatment
por: Chiang, John Y. L.
Publicado: (2017) -
Autophagy: A Cellular Guardian against Hepatic Lipotoxicity
por: Sinha, Rohit Anthony
Publicado: (2023)